Na Liu

5.0k total citations · 1 hit paper
134 papers, 3.8k citations indexed

About

Na Liu is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Na Liu has authored 134 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Nephrology, 61 papers in Molecular Biology and 22 papers in Surgery. Recurrent topics in Na Liu's work include Dialysis and Renal Disease Management (26 papers), Chronic Kidney Disease and Diabetes (22 papers) and Histone Deacetylase Inhibitors Research (18 papers). Na Liu is often cited by papers focused on Dialysis and Renal Disease Management (26 papers), Chronic Kidney Disease and Diabetes (22 papers) and Histone Deacetylase Inhibitors Research (18 papers). Na Liu collaborates with scholars based in China, United States and Sweden. Na Liu's co-authors include Shougang Zhuang, Yingfeng Shi, Jinhua Tang, Liuqing Xu, Haidong Yan, Andong Qiu, George Bayliss, Evelyn Tolbert, Murugavel Ponnusamy and Xiaoyan Ma and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Na Liu

127 papers receiving 3.8k citations

Hit Papers

The Role of the Intestine in the Development of Hyperuric... 2022 2026 2023 2024 2022 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Role of the Intestine in the Development of Hyperuricemia
    2022 97 citations Na Liu et al. profile →

Peers

Na Liu
Haiping Mao China
Gianluigi Zaza Italy
Hong Liu China
Niansong Wang China
Sandra Rayego‐Mateos Spain
Didier Portilla United States
Jinghong Zhao China
Adrián M. Ramos Spain
Shan Mou China
Haiyan Fu China
Haiping Mao China
Na Liu
Citations per year, relative to Na Liu Na Liu (= 1×) peers Haiping Mao

Countries citing papers authored by Na Liu

Since Specialization
Citations

This map shows the geographic impact of Na Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Liu more than expected).

Fields of papers citing papers by Na Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Liu. The network helps show where Na Liu may publish in the future.

Co-authorship network of co-authors of Na Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Na Liu. A scholar is included among the top collaborators of Na Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Liu. Na Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuhan, Yizhe Li, Na Liu, et al.. (2025). Notch2 Inhibition and Kidney Cyst Growth in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology. 36(5). 781–797. 1 indexed citations
2.
Zheng, Rui, Yu Liu, Yuwei Wang, et al.. (2025). PPDPF preserves integrity of proximal tubule by modulating NMNAT activity in chronic kidney diseases. Science Advances. 11(12). eadr8648–eadr8648. 1 indexed citations
3.
4.
Shi, Yingfeng, Jinqing Li, Hui Chen, et al.. (2025). Inhibition of Caspase‐1 Suppresses GSDMD‐mediated Peritoneal Mesothelial Cell Pyroptosis and Inflammation in Peritoneal Fibrosis. Small. 21(14). e2409362–e2409362. 2 indexed citations
5.
6.
Chen, Si, Xiaoyan Ma, Xun Zhou, et al.. (2022). An updated clinical prediction model of protein-energy wasting for hemodialysis patients. Frontiers in Nutrition. 9. 933745–933745. 2 indexed citations
7.
Tao, Min, Xiaoyan Ma, Yingfeng Shi, et al.. (2021). Prevalence and related factors of hyperuricaemia in Shanghai adult women of different ages: a multicentre and cross-sectional study. BMJ Open. 11(9). e048405–e048405. 4 indexed citations
8.
Zhao, Dongyang, Chunxue Wang, Xiandong Liu, et al.. (2021). CircN4bp1 Facilitates Sepsis‐Induced Acute Respiratory Distress Syndrome through Mediating Macrophage Polarization via the miR‐138‐5p/EZH2 Axis. Mediators of Inflammation. 2021(1). 7858746–7858746. 28 indexed citations
9.
Ma, Xiaoyan, Yingfeng Shi, Min Tao, et al.. (2020). Analysis of risk factors and outcome in peritoneal dialysis patients with early-onset peritonitis: a multicentre, retrospective cohort study. BMJ Open. 10(2). e029949–e029949. 26 indexed citations
10.
Li, Jinxiao, Na Liu, Huarong Li, et al.. (2020). HDAC3 deteriorates colorectal cancer progression via microRNA-296-3p/TGIF1/TGFβ axis. Journal of Experimental & Clinical Cancer Research. 39(1). 248–248. 29 indexed citations
11.
Wang, Dongyuan, Wenjun Li, Longjian Chen, et al.. (2019). Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate H3K56 for the Treatment of Cancer Stem–Like Cells In Vivo. Cancer Research. 79(8). 1769–1783. 33 indexed citations
12.
13.
Huang, Yahui, Guoqiang Dong, Huanqiu Li, et al.. (2018). Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections. Journal of Medicinal Chemistry. 61(14). 6056–6074. 91 indexed citations
14.
Liu, Na, Yue Ma, Dongyuan Wang, et al.. (2018). The Development of Epigenetics and Related Inhibitors for Targeted Drug Design in Cancer Therapy. Current Topics in Medicinal Chemistry. 18(28). 2380–2394. 16 indexed citations
15.
Liu, Na, Zhichao Ma, & Yuan Li. (2015). The utility of Lanzhou Lamb Rotavirus Vaccine among children under 5 in two vaccination sites of Shenzhen. 29(2). 151–153. 2 indexed citations
16.
Wang, Li, Liuqing Xu, Yingfeng Shi, et al.. (2015). Establishment of uric acid associated nephropathy animal model and the underlying mechanisms. 31(3). 203–207. 2 indexed citations
17.
Wang, Yanqiu, Bowen Wang, Feng Du, et al.. (2015). Epigallocatechin‐3‐Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF‐κB and Nrf2/HO‐1 Signalling Pathway Regulation. Basic & Clinical Pharmacology & Toxicology. 117(3). 164–172. 77 indexed citations
18.
19.
Liu, Na, Evelyn Tolbert, Murugavel Ponnusamy, Haidong Yan, & Shougang Zhuang. (2011). Delayed Administration of Suramin Attenuates the Progression of Renal Fibrosis in Obstructive Nephropathy. Journal of Pharmacology and Experimental Therapeutics. 338(3). 758–766. 27 indexed citations
20.
Pang, Maoyin, Li Ma, Na Liu, et al.. (2011). Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins. Journal of Cellular Biochemistry. 112(8). 2138–2148. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haiping Mao Breakdown of academic impact, for papers by Gianluigi Zaza Breakdown of academic impact, for papers by Hong Liu Breakdown of academic impact, for papers by Niansong Wang Breakdown of academic impact, for papers by Sandra Rayego‐Mateos Breakdown of academic impact, for papers by Didier Portilla Breakdown of academic impact, for papers by Jinghong Zhao Breakdown of academic impact, for papers by Adrián M. Ramos Breakdown of academic impact, for papers by Shan Mou Breakdown of academic impact, for papers by Haiyan Fu
Rankless by CCL
2026